$XOS
Xos, Inc. Stock $xos

$xos Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-Q Financial Statement

#000181949321000009 Filed on November 12, 2021

Income Statement

Concept	2021 Q4	2021 Q3	2020 Q4
Revenue	$3.302M	$357.0K	$943.0K
YoY Change	250.16%	-68.27%
Cost Of Revenue	$5.735M	$418.0K	$702.0K
YoY Change	716.95%	-64.0%
Gross Profit	-$2.433M	-$61.00K	$241.0K
YoY Change	-1109.54%	69.44%
Gross Profit Margin	-73.68%	-17.09%	25.56%
Selling, General & Admin	$10.44M	$10.76M	$3.035M
YoY Change	243.86%	375.48%
% of Gross Profit			1259.34%
Research & Development	$13.21M	$3.237M	$2.140M
YoY Change	517.29%	345.25%
% of Gross Profit			887.97%
Depreciation & Amortization	$108.0K	$248.0K	$148.0K
YoY Change	-27.03%	275.76%
% of Gross Profit			61.41%
Operating Expenses	$23.02M	$14.25M	$5.254M
YoY Change	338.1%	366.13%
Operating Profit	-$25.45M	-$14.31M	-$5.013M
YoY Change	407.7%	362.68%
Interest Expense	$12.58M	$65.00K	-$2.609M
YoY Change	-582.33%	-92.5%
% of Operating Profit
Other Income/Expense, Net	$24.31M	$49.20M	-$4.000K
YoY Change	-607800.0%	-5774.97%
Pretax Income	$11.44M	$34.90M	-$7.626M
YoY Change	-250.03%	-981.21%
Income Tax	$2.000K	$0.00
% Of Pretax Income	0.02%	0.0%
Net Earnings	$11.44M	$34.90M	-$7.626M
YoY Change	-250.0%	-981.43%
Net Earnings / Revenue	346.43%	9774.79%	-808.7%
Basic Earnings Per Share		$0.31
Diluted Earnings Per Share	$69.88K	-$0.08	-$47.02K
COMMON SHARES
Basic Shares Outstanding	162.9M shares	113.8M shares
Diluted Shares Outstanding		148.8M shares

Balance Sheet

Concept	2021 Q4	2021 Q3	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$110.8M	$211.5M	$10.36M
YoY Change	969.97%
Cash & Equivalents	$16.14M	$207.4M	$10.36M
Short-Term Investments	$94.70M	$4.085M	$0.00
Other Short-Term Assets	$18.10M	$1.484M	$0.00
YoY Change
Inventory	$30.88M	$20.80M	$1.867M
Prepaid Expenses
Receivables	$3.353M	$583.0K	$408.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$166.0M	$246.6M	$12.69M
YoY Change	1207.79%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.426M	$4.629M	$1.084M
YoY Change	585.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$54.82M
YoY Change
Other Assets	$506.0K	$505.0K	$0.00
YoY Change
Total Long-Term Assets	$62.75M	$5.134M	$1.084M
YoY Change	5688.56%
TOTAL ASSETS
Total Short-Term Assets	$166.0M	$246.6M	$12.69M
Total Long-Term Assets	$62.75M	$5.134M	$1.084M
Total Assets	$228.7M	$251.8M	$13.77M
YoY Change	1560.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.12M	$12.47M	$1.168M
YoY Change	766.61%
Accrued Expenses	$4.303M	$1.151M	$1.837M
YoY Change	134.24%
Deferred Revenue	$899.0K	$1.187M	$731.0K
YoY Change	22.98%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$482.0K	$151.0K
YoY Change
Total Short-Term Liabilities	$15.98M	$15.46M	$32.94M
YoY Change	-51.48%
LONG-TERM LIABILITIES
Long-Term Debt	$1.594M	$876.0K
YoY Change
Other Long-Term Liabilities	$36.74M	$73.51M
YoY Change
Total Long-Term Liabilities	$38.33M	$74.38M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.98M	$15.46M	$32.94M
Total Long-Term Liabilities	$38.33M	$74.38M
Total Liabilities	$54.31M	$89.84M	$33.11M
YoY Change	64.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.093M	-$15.61M	-$27.49M
YoY Change	-85.11%
Common Stock	$16.00K	$16.00K	$7.000K
YoY Change	128.57%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$174.4M	$161.9M	-$27.20M
YoY Change
Total Liabilities & Shareholders Equity	$228.7M	$251.8M	$13.77M
YoY Change	1560.42%

Cashflow Statement

Concept	2021 Q4	2021 Q3	2020 Q4
OPERATING ACTIVITIES
Net Income	$11.44M	$34.90M	-$7.626M
YoY Change	-250.0%	-981.43%
Depreciation, Depletion And Amortization	$108.0K	$248.0K	$148.0K
YoY Change	-27.03%	275.76%
Cash From Operating Activities	-$35.76M	-$32.98M	-$8.298M
YoY Change	330.95%	467.68%
INVESTING ACTIVITIES
Capital Expenditures	-$1.572M	-$2.641M	-$264.0K
YoY Change	495.45%	-1010.69%
Acquisitions
YoY Change
Other Investing Activities	-$150.2M
YoY Change
Cash From Investing Activities	-$151.8M	-$2.641M	-$264.0K
YoY Change	57400.0%	810.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-652.0K	219.4M	10.05M
YoY Change	-106.49%	10924.82%
NET CHANGE
Cash From Operating Activities	-35.76M	-32.98M	-8.298M
Cash From Investing Activities	-151.8M	-2.641M	-264.0K
Cash From Financing Activities	-652.0K	219.4M	10.05M
Net Change In Cash	-188.2M	183.8M	1.487M
YoY Change	-12757.16%	-4571.31%
FREE CASH FLOW
Cash From Operating Activities	-$35.76M	-$32.98M	-$8.298M
Capital Expenditures	-$1.572M	-$2.641M	-$264.0K
Free Cash Flow	-$34.19M	-$30.34M	-$8.034M
YoY Change	325.54%	397.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Central Index Key EntityCentralIndexKey	0001819493
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-39598
	dei	Entity Registrant Name EntityRegistrantName	XOS, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1550505
	dei	Entity Address Address Line1 EntityAddressAddressLine1	3550 Tyburn Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90065
	dei	City Area Code CityAreaCode	818
	dei	Local Phone Number LocalPhoneNumber	316-1890
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	162904938	shares
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	207388000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10359000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	583000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	408000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	20834000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1867000	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17840000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	246645000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	12690000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4629000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1084000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	505000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	0	USD
CY2021Q3	us-gaap	Assets Assets	251779000	USD
CY2020Q4	us-gaap	Assets Assets	13774000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12468000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1168000	USD
CY2021Q3	us-gaap	Loans Payable Current LoansPayableCurrent	151000	USD
CY2020Q4	us-gaap	Loans Payable Current LoansPayableCurrent	142000	USD
CY2021Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	18360000	USD
CY2021Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2020Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	6394000	USD
CY2021Q3	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	0	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2021Q3	xos	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	0	USD
CY2020Q4	xos	Warrants And Rights Outstanding Current WarrantsAndRightsOutstandingCurrent	1707000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2836000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5142000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	15455000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	32943000	USD
CY2021Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable	876000	USD
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	166000	USD
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	53542000	USD
CY2020Q4	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	0	USD
CY2021Q3	xos	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	19963000	USD
CY2020Q4	xos	Warrants And Rights Outstanding Noncurrent WarrantsAndRightsOutstandingNoncurrent	0	USD
CY2021Q3	us-gaap	Liabilities Liabilities	89836000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	33109000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2021Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	27041000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	27041000	shares
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	0	shares
CY2020Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	2762000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2762000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	72277000	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7862000	USD
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	162905000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	162905000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	72277000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	16000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	7000	USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	177533000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	290000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-15606000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27494000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	161943000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-27197000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	251779000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13774000	USD
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	700000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1698000	USD
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	418000	USD
CY2020Q3	us-gaap	Cost Of Revenue CostOfRevenue	1161000	USD
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	357000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1125000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1746000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1675000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	1639000	USD
CY2021Q3	us-gaap	Gross Profit GrossProfit	-61000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	-36000	USD
	us-gaap	Gross Profit GrossProfit	71000	USD
	us-gaap	Gross Profit GrossProfit	59000	USD
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3237000	USD
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	727000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6867000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2440000	USD
CY2021Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	549000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	19580000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4122000	USD
	us-gaap	Depreciation Depreciation	214000	USD
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	14245000	USD
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	3056000	USD
	us-gaap	Operating Expenses OperatingExpenses	27775000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	142000	USD
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10211000	USD
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2198000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	248000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	66000	USD
	us-gaap	Depreciation Depreciation	628000	USD
	us-gaap	Operating Expenses OperatingExpenses	6918000	USD
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-14306000	USD
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3092000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-27704000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-6859000	USD
CY2021Q3	us-gaap	Interest Expense InterestExpense	65000	USD
CY2020Q3	us-gaap	Interest Expense InterestExpense	867000	USD
	us-gaap	Interest Expense InterestExpense	78000	USD
	us-gaap	Interest Expense InterestExpense	2186000	USD
CY2021Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1066000	USD
CY2020Q3	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6030000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
CY2021Q3	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-48202000	USD
CY2020Q3	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	USD
	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-48202000	USD
	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	USD
CY2021Q3	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	USD
CY2020Q3	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	USD
	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	379000	USD
	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	USD
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	USD
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	49202000	USD
CY2020Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-867000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39666000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2182000	USD
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14104000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2021Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1000	USD
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	34896000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-3959000	USD
	us-gaap	Net Income Loss NetIncomeLoss	11962000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9041000	USD
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.31
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72277000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	86192000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	113797000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	72145000	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	148791000	shares
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72277000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	121186000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	72145000	shares
CY2020Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	2762000	shares
CY2020Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	7862000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-27197000	USD
CY2021Q1	xos	Temporary Equity Shares Subscribed But Unissued Subscriptions Receivable Payment TemporaryEquitySharesSubscribedButUnissuedSubscriptionsReceivablePayment	2430000	USD
CY2021Q1	xos	Adjustments To Additional Paid In Capital Payment Of Temporary Equity Subscription Receivable AdjustmentsToAdditionalPaidInCapitalPaymentOfTemporaryEquitySubscriptionReceivable	306000	USD
CY2021Q1	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	49518000	shares
CY2021Q1	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	66701000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	USD
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2000	USD
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-13776000	USD
CY2021Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	52280000	shares
CY2021Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	76993000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-40663000	USD
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2000	USD
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	-9158000	USD
CY2021Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	52280000	shares
CY2021Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	76993000	USD
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	-49819000	USD
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	7000	USD
CY2021Q3	xos	Temporary Equity Stock Issued During Period Shares Preferred Stock Warrant Exercised TemporaryEquityStockIssuedDuringPeriodSharesPreferredStockWarrantExercised	625000	shares
CY2021Q3	xos	Temporary Equity Stock Issued During Period Value Preferred Stock Warrant Exercised TemporaryEquityStockIssuedDuringPeriodValuePreferredStockWarrantExercised	2715000	USD
CY2021Q3	xos	Temporary Equity Stock Issued During Period Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	-52905000	shares
CY2021Q3	xos	Temporary Equity Stock Issued During Period Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-79708000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	79772000	USD
CY2021Q3	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	55424000	USD
CY2021Q3	xos	Stock Issued During Period Value Reverse Recapitalization StockIssuedDuringPeriodValueReverseRecapitalization	20721000	USD
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	196000000	USD
CY2021Q3	xos	Adjustments To Additional Paid In Capital Warrants Recognized In Reverse Recapitalization AdjustmentsToAdditionalPaidInCapitalWarrantsRecognizedInReverseRecapitalization	17891000	USD
CY2021Q3	xos	Adjustments To Additional Paid In Capital Recognition Of Derivative Instrument Contingent Consideration Liability AdjustmentsToAdditionalPaidInCapitalRecognitionOfDerivativeInstrumentContingentConsiderationLiability	101744000	USD
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	34896000	USD
CY2021Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2021Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	161943000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-10534000	USD
CY2019Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2019Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-1237000	USD
CY2020Q1	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-11771000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-3845000	USD
CY2020Q2	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q2	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-15610000	USD
CY2020Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6000	USD
CY2020Q3	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	3000	USD
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3000	USD
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-3959000	USD
CY2020Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	0	shares
CY2020Q3	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-19563000	USD
	us-gaap	Net Income Loss NetIncomeLoss	11962000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-9041000	USD
	us-gaap	Depreciation Depreciation	628000	USD
	us-gaap	Depreciation Depreciation	214000	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
	us-gaap	Paid In Kind Interest PaidInKindInterest	2186000	USD
	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	379000	USD
	xos	Write Off Of Shares Subscribed But Unissued Subscriptions Receivable WriteOffOfSharesSubscribedButUnissuedSubscriptionsReceivable	0	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-14104000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	6030000	USD
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	0	USD
	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-48202000	USD
	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	5000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	7000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	175000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	904000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18967000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1616000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	17784000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	278000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	505000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	376000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	11300000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-346000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	150000	USD
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	305000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-53135000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9849000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3343000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	427000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3343000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	253507000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15026000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-427000	USD
	xos	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	20721000	USD
	xos	Proceeds From Reverse Recapitalization ProceedsFromReverseRecapitalization	0	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	196000000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	USD
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	31757000	USD
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	1646000	USD
	xos	Proceeds From Collection Of Temporary Equity Subscription Receivable ProceedsFromCollectionOfTemporaryEquitySubscriptionReceivable	2430000	USD
	xos	Proceeds From Collection Of Temporary Equity Subscription Receivable ProceedsFromCollectionOfTemporaryEquitySubscriptionReceivable	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	13440000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2715000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	126000	USD
	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	60000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	197029000	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4750000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10359000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	19000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	207388000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4769000	USD
	xos	Debt Conversion Converted Instrument Interest Payable Amount DebtConversionConvertedInstrumentInterestPayableAmount	2453000	USD
	xos	Debt Conversion Converted Instrument Interest Payable Amount DebtConversionConvertedInstrumentInterestPayableAmount	0	USD
	xos	Fair Value Adjustment Of Related Party Debt At Conversion FairValueAdjustmentOfRelatedPartyDebtAtConversion	3763000	USD
	xos	Fair Value Adjustment Of Related Party Debt At Conversion FairValueAdjustmentOfRelatedPartyDebtAtConversion	0	USD
	us-gaap	Stock Issued1 StockIssued1	34918000	USD
	us-gaap	Stock Issued1 StockIssued1	0	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	21540000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	79708000	USD
	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	0	USD
	xos	Noncash Or Part Noncash Acquisition Warrants Assumed NoncashOrPartNoncashAcquisitionWarrantsAssumed	17891000	USD
	xos	Noncash Or Part Noncash Acquisition Warrants Assumed NoncashOrPartNoncashAcquisitionWarrantsAssumed	0	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	101744000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	55424000	USD
	xos	Reverse Recapitalization Transaction Costs ReverseRecapitalizationTransactionCosts	0	USD
	us-gaap	Use Of Estimates UseOfEstimates	The preparation of financial statements in conformity with U.S. GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenues and expenses during the reporting periods. The areas with significant estimates and judgments include, among others, share-based compensation, the fair value of the Company’s Common Stock and Preferred Stock, valuation of the convertible notes and the related embedded derivative, SAFE Note (as defined below), Warrants and warrant liability on Legacy Xos Preferred Stock. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates, and such differences could be material to the Company’s financial statements.
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	357000	USD
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1125000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1746000	USD
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1698000	USD
CY2021Q3	us-gaap	Inventory Net InventoryNet	20800000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	1900000	USD
CY2021Q3	xos	Payments Of Reverse Recapitalization Transaction Costs PaymentsOfReverseRecapitalizationTransactionCosts	44200000	USD
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability DerivativeInstrumentContingentConsiderationLiability	101700000	USD
CY2021Q3	xos	Recapitalization Exchange Ratio RecapitalizationExchangeRatio	1.956440
CY2021Q3	xos	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	142584621	shares
CY2021Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	19600000	shares
CY2021Q3	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	10.00
CY2021Q3	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	196000000	USD
CY2021Q3	xos	Sale Of Stock Consideration Not Funded SaleOfStockConsiderationNotFunded	4000000	USD
CY2021Q3	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17900000	USD
	xos	Cash Acquired Through Reverse Recapitalization CashAcquiredThroughReverseRecapitalization	76145000	USD
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	196000000	USD
	xos	Payments Of Reverse Recapitalization Underwriters Fees PaymentsOfReverseRecapitalizationUnderwritersFees	24285000	USD
	xos	Payments Of Reverse Recapitalization Other Transaction Costs PaymentsOfReverseRecapitalizationOtherTransactionCosts	31139000	USD
	xos	Reverse Recapitalization Net ReverseRecapitalizationNet	216721000	USD
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	19600000	shares
	xos	Stock Issued During Period Shares Reverse Recapitalization StockIssuedDuringPeriodSharesReverseRecapitalization	162184621	shares
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Shares DerivativeInstrumentContingentConsiderationLiabilityShares	16200000	shares
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Fair Value Disclosure DerivativeInstrumentContingentConsiderationLiabilityFairValueDisclosure	101700000	USD
CY2021Q3	xos	Derivative Instrument Contingent Consideration Liability Fair Value Disclosure DerivativeInstrumentContingentConsiderationLiabilityFairValueDisclosure	53500000	USD
CY2021Q3	xos	Derivative Instrument Change In Amount Of Contingent Consideration Liability DerivativeInstrumentChangeInAmountOfContingentConsiderationLiability	-48200000	USD
CY2021Q3	xos	Capital Stock Shares Authorized CapitalStockSharesAuthorized	1010000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	xos	Common Stock Voting Rights Number Of Votes CommonStockVotingRightsNumberOfVotes	1	vote
	xos	Class Of Warrant Or Right Fair Market Value Threshold Consecutive Trading Days Ending On Third Trading Day Prior To Notice Of Redemption ClassOfWarrantOrRightFairMarketValueThresholdConsecutiveTradingDaysEndingOnThirdTradingDayPriorToNoticeOfRedemption	P10D
CY2020Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	319411	shares
CY2020Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	8.50
CY2020Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2020Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	1700000	USD
	xos	Warrants And Rights Outstanding Merger Percentage Probability Of Occurrence With Per Share Value Determined On A Discounted Basis WarrantsAndRightsOutstandingMergerPercentageProbabilityOfOccurrenceWithPerShareValueDeterminedOnADiscountedBasis	0.75
	xos	Warrants And Rights Outstanding Merger Percentage Probability Of Occurrence With Per Share Value Determined Based On Equal5050 Weighting Of The Market Approach And Income Approach WarrantsAndRightsOutstandingMergerPercentageProbabilityOfOccurrenceWithPerShareValueDeterminedBasedOnEqual5050WeightingOfTheMarketApproachAndIncomeApproach	0.25
CY2021Q3	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	2700000	USD
CY2020Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	6400000	USD
CY2021Q3	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	0	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	10000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7000	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2020Q4	xos	Safe Note Percentage Of Price Per Share In Calculation For Conversion Into Temporary Equity SAFENotePercentageOfPricePerShareInCalculationForConversionIntoTemporaryEquity	0.80
CY2021Q1	xos	Proceeds From The Conversion Of Safe Notes ProceedsFromTheConversionOfSAFENotes	620000	USD
CY2020Q4	xos	Simple Agreement For Future Equity Notes Payable Current SimpleAgreementForFutureEquityNotesPayableCurrent	30000	USD
CY2021Q1	xos	Temporary Equity Stock Issued During Period Shares New Issues TemporaryEquityStockIssuedDuringPeriodSharesNewIssues	76471	shares
CY2021Q3	us-gaap	Deposits Assets Current DepositsAssetsCurrent	4085000	USD
CY2020Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	0	USD
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	6946000	USD
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	48000	USD
CY2021Q3	xos	Prepaid Inventory PrepaidInventory	5325000	USD
CY2020Q4	xos	Prepaid Inventory PrepaidInventory	8000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	1484000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	0	USD
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17840000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	56000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	5936000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1761000	USD
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1307000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	677000	USD
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4629000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1084000	USD
CY2021Q3	us-gaap	Depreciation Depreciation	248000	USD
CY2020Q3	us-gaap	Depreciation Depreciation	66000	USD
	us-gaap	Depreciation Depreciation	628000	USD
	us-gaap	Depreciation Depreciation	214000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1187000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1837000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1151000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	468000	USD
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	0	USD
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2453000	USD
CY2021Q3	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	498000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	384000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2836000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	5142000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	1124000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	1158000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	1192000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	1228000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	1370000	USD
CY2021Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	6072000	USD
CY2021Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	170000	USD
CY2020Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	115000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	449000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	173000	USD
CY2021Q3	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	364000	USD
CY2021Q3	xos	Notes Payable Related Parties Interest Rate Stated Percentage NotesPayableRelatedPartiesInterestRateStatedPercentage	0.0238
CY2021Q3	us-gaap	Notes Payable Related Parties Current And Noncurrent NotesPayableRelatedPartiesCurrentAndNoncurrent	364000	USD
CY2020	xos	Notes Payable Related Parties Accrued Interest NotesPayableRelatedPartiesAccruedInterest	15000	USD
	xos	Number Of Vehicles Acquired From Related Party NumberOfVehiclesAcquiredFromRelatedParty	2	vehicle
	xos	Notes Payable Related Parties Number Of Notes Payable Converted NotesPayableRelatedPartiesNumberOfNotesPayableConverted	34	note_payable
CY2021Q3	xos	Temporary Equity Stock Issued During Period To Related Parties Value Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodToRelatedPartiesValueConversionOfConvertibleSecurities	18900000	USD
CY2021Q3	xos	Temporary Equity Stock Issued During Period To Related Parties Shares Conversion Of Convertible Securities TemporaryEquityStockIssuedDuringPeriodToRelatedPartiesSharesConversionOfConvertibleSecurities	19664000	USD
	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	57000	USD
CY2021Q3	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	53200000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	15600000	USD

Files In Submission

Name	View Source	Status
0001819493-21-000009-index-headers.html	Edgar Link	pending
0001819493-21-000009-index.html	Edgar Link	pending
0001819493-21-000009.txt	Edgar Link	pending
0001819493-21-000009-xbrl.zip	Edgar Link	pending
ex-101xarnonxemployeedirec.htm	Edgar Link	pending
ex-311xdsemler.htm	Edgar Link	pending
ex-312xkafemikhe.htm	Edgar Link	pending
ex-321xdsemlerandkafemikhe.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
xos-20210930.htm	Edgar Link	pending
xos-20210930.xsd	Edgar Link	pending
xos-20210930_cal.xml	Edgar Link	unprocessable
xos-20210930_def.xml	Edgar Link	unprocessable
xos-20210930_g1.jpg	Edgar Link	pending
xos-20210930_htm.xml	Edgar Link	completed
xos-20210930_lab.xml	Edgar Link	unprocessable
xos-20210930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$XOS
Xos, Inc. Stock $xos

2021 Q4 Form 10-Q Financial Statement

#000181949321000009 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XOS Xos, Inc. Stock $xos

2021 Q4 Form 10-Q Financial Statement

#000181949321000009 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$XOS
Xos, Inc. Stock $xos